Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Summary

Whitehawk Therapeutics (Nasdaq: WHWK) announced that Dave Lennon, PhD, President and CEO, will participate in a fireside discussion at the Piper Sandler 37th Annual Healthcare Conference in New York City on December 3, 2025 at 12:30 PM ET. A live webcast will be available on the company's investor relations website and will be replayable for approximately 30 days after the event.

MORRISTOWN, N.J., Nov. 26, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) cancer treatments, today announced that Dave Lennon, PhD, President and CEO, will participate in a fireside discussion at the Piper Sandler 37th Annual Healthcare Conference in New York City, NY on December 3, 2025, at 12:30 PM ET.

A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IR website and will be available for replay for approximately 30 days following the event.

About Whitehawk Therapeutics
Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement. More information on the Company is available at www.whitehawktx.com and connect with us on LinkedIn.

Contact:
IR@whitehawktx.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference-302626225.html

SOURCE Whitehawk Therapeutics, Inc.

FAQ

When will Whitehawk Therapeutics (WHWK) present at the Piper Sandler 2025 conference?

Whitehawk Therapeutics will present on December 3, 2025 at 12:30 PM ET.

How can investors watch the Whitehawk Therapeutics (WHWK) fireside chat on December 3, 2025?

Investors can watch a live webcast via the Whitehawk Therapeutics investor relations website.

Will the Whitehawk Therapeutics (WHWK) webcast be available after the Piper Sandler conference?

Yes, the webcast will be available for replay for approximately 30 days following the event.

Who will represent Whitehawk Therapeutics (WHWK) at the Piper Sandler 37th Annual Healthcare Conference?

Dave Lennon, PhD, President and CEO of Whitehawk Therapeutics, will participate in the fireside discussion.

Where is the Piper Sandler 37th Annual Healthcare Conference taking place for the Whitehawk Therapeutics (WHWK) presentation?

The conference is in New York City, NY, where the fireside discussion will be held.